Equities

Advanced Medical Solutions Group PLC

Advanced Medical Solutions Group PLC

Actions
Health CareHealth Care Equipment & Services
  • Price (GBX)298.00
  • Today's Change-0.50 / -0.17%
  • Shares traded1.03m
  • 1 Year change52.43%
  • Beta0.1435
Data delayed at least 20 minutes, as of Jun 23 2017 18:13 BST.
More ▼

Key statistics

Advanced Medical Solutions Group PLC (AMS:LSE) set a new 52-week high during Thursday's trading session when it reached 307.60. Over this period, the share price is up 57.67%.
52-week range
Today
180.00Jun 24 2016307.60Jun 22 2017
Markit short selling activity
Low
Med
High
Open300.00
High302.00
Low296.75
Bid281.00
Offer298.75
Previous close298.50
Average volume498.58k
Shares outstanding211.61m
Free float198.66m
P/E (TTM)40.44
Market cap631.67m GBP
EPS (TTM)0.0738
GBP
Annual div (ADY)0.92
GBX
Annual div yield (ADY)0.31%
Div ex-dateMay 25 2017
Div pay-dateJun 16 2017
Data delayed at least 20 minutes, as of Jun 23 2017 18:13 BST.
More ▼

Investors Chronicle View

The last IC recommendation on Advanced Medical Solutions Group PLC shares was Buy at 236.00 on 14 Mar 2017Read the full article

Board of Directors

1/6

Peter V Allen BA (Hons), Non-Executive Chairman

2/6

Chris Meredith BSc (Hons), Chief Executive Officer

3/6

Mary G Tavener ACMA, MCT, BA (Hons) Chem (Oxon), Finance Director

4/6

Penelope Anne Freer, Senior Independent Non-Executive Director

5/6

Stephen G Bellamy BCom & ACA (NZ), Non-Executive Director

6/6

Peter Steinmann, Non-Executive Director

© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.